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The DREF [DRE (DNA replication-related element)-binding
factor], which regulates the transcription of a group of cell
proliferation-related genes in Drosophila, also controls the
expression of three genes involved in mtDNA (mitochondrial
DNA) replication and maintenance. In the present study, by
in silico analysis, we have identified DREs in the promoter region
of a gene participating in mtDNA transcription, the DmTTF
(Drosophila mitochondrial transcription termination factor).
Transient transfection assays in Drosophila S2 cells, with mutated
versions of DmTTF promoter region, showed that DREs control
DmTTF transcription; moreover, gel-shift and ChIP (chromatin
immunoprecipitation) assays demonstrated that the analysed DRE
sites interact with DREF in vitro and in vivo. Accordingly,
DREF knock-down in S2 cells by RNAi (RNA interference)
induced a considerable decrease in DmTTF mRNA level. These
results clearly demonstrate that DREF positively controls DmTTF
expression. On the other hand, mtRNApol (mitochondrial RNA
polymerase) lacks DREs in its promoter and is not regulated
in vivo by DREF. In situ RNA hybridization studies showed
that DmTTF was transcribed almost ubiquitously throughout
all stages of Drosophila embryogenesis, whereas mtRNApol
was efficiently transcribed from stages 11–12. Territories where
transcription occurred mostly were the gut and Malpighi tubes
for DmTTF, and the gut, mesoderm, pharyngeal muscle and
Malpighi tubes for mtRNApol. The partial overlapping in the
temporal and spatial mRNA expression patterns confirms that
transcription of the two genes is differentially regulated during
embryogenesis and suggests that DmTTF might play multiple
roles in the mtDNA transcription process, for which different
levels of the protein with respect to mtRNApol are required.
Key words: chromatin immunoprecipitation (ChIP), DNA rep-
lication-related element (DRE)-binding factor (DREF), Droso-
phila mitochondrial transcription termination factor (DmTTF),
embryogenesis, mitochondrial RNA polymerase (mtRNApol),
RNA interference (RNAi).
INTRODUCTION
Mitochondria are semi-autonomous cytoplasmic organelles
whose biogenesis requires the co-ordinate expression of nuclear
and mitochondrial genomes. The coding capacity of animal
mtDNA (mitochondrial DNA) is limited to 13 polypeptides of
the OXPHOS (oxidative phosphorylation system), 22 tRNAs and
two rRNAs; thus most of the mitochondrial proteins includ-
ing respiratory complex polypeptides, metabolic enzymes and
proteins involved in mtDNA replication and expression are
nuclear encoded [1,2]. Many efforts have been made to clarify
the mechanisms that regulate the expression of nuclear genes
encoding mitochondrial proteins. In mammals, two nuclear
transcription factors, namely NRF-1 (nuclear respiratory factor-1)
and NRF-2, have been shown to regulate, in co-operation with
co-activators of the PGC-1 (peroxisome-proliferator-activated
receptor γ co-activator) family, the expression of many nuclear
genes encoding proteins involved in mitochondrial biogenesis
and function [3]. In Drosophila, erect wing, the NRF-1
orthologue that regulates myogenesis and neurogenesis, has never
been demonstrated to co-ordinate mitochondrial protein gene
expression [4,5]. Recently, in silico analysis of the Drosophila
melanogaster genome has led to the identification of a single, ten-
nucleotide long sequence, named NRG (nuclear respiratory gene)
element, in more than 50% of genes with mitochondrial function,
including the electron transport chain, oxidative metabolism and
mitochondrial biogenesis [6].
The DREF [DRE (DNA replication-related element)-binding
factor] is a Drosophila transcription-regulatory protein consisting
of an 80 kDa polypeptide forming a homodimer that specifically
binds DRE sequences [7]. They constitute an eight-nucleotide
long palindromic consensus sequence that was initially shown to
be required for the expression of genes involved in nuclear DNA
replication and cell cycle control [8–11]. DREF may either func-
tion as a bona fide transcription factor, as its binding sites are loc-
ated up to more than 1 kb upstream of the transcription start point
of the controlled genes [12–14], or may be part of the basal tran-
scription machinery involved in recognizing core promoters [15].
Interestingly, it has been demonstrated that DREF also controls
the expression of genes, such as the mtSSB (mitochondrial
single-stranded DNA-binding) protein, the β-subunit of the
mitochondrial DNA polymerase (pol γ -β) and the TFAM (mito-
chondrial transcription factor A), whose products are required
for mtDNA replication and maintenance [16–18], thus providing
evidence for a co-ordinated regulation of nuclear and mito-
chondrial DNA replication. No information concerning the
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control by the DRE/DREF system on proteins that are specifically
involved in mtDNA transcription are available yet; therefore
we wished to investigate the possible dependence on DREF of
the genes for the single-subunit mtRNApol (mitochondrial RNA
polymerase) and for the accessory factor DmTTF (Drosophila
mitochondrial transcription termination factor). DmTTF is
a nuclear encoded 43 kDa protein member of the mTERF
(mitochondrial termination factor) protein family [19,20]. It acts
as a transcription termination factor in Drosophila mitochondria
by arresting the progression of mtRNApol at its two DNA-binding
sites, both of which are located at the 3′-end of clusters of genes
transcribed in a convergent direction [21,22]. Moreover, it appears
that DmTTF has a broad effect on mitochondrial transcription,
since its depletion alters the level of those mitochondrial RNAs
that map upstream of its binding sites, thus pointing towards a
possible function also in transcription initiation [22].
In the present paper, by a combination of in vitro and
in vivo experiments, we demonstrate that DREF binds two DRE
sequences located approx. 50 nt upstream of the DmTTF trans-
cription initiation site and that it positively regulates the
expression of DmTTF. On the other hand, no control by
the DRE/DREF system was observed for the mtRNApol gene.
In addition, by analysing the temporal and spatial accumulation
of both DmTTF and mtRNApol mRNAs during Drosophila
embryogenesis, we found that the two mRNAs show common
patterns of significant expression in the gut and Malpighi tubes
and distinct profiles in other regions.
MATERIALS AND METHODS
Promoter constructs
Construction of p2000DDD and mutant derivatives
A 2076 bp DNA fragment upstream of the D. melanogaster
DmTTF coding region (from –1964 to +112, considering +1 as
the transcription start point and +113 being the first nucleotide
of the start codon) was obtained by PCR using total DNA
from the D. melanogaster derivative S2 cell line as a template, and
the forward primer dir(1339) (5′-CCGGATCCCTTCAATTG-
TCACTTGTCATT-3′) and the reverse primer rev(818) (5′-
GGCTCGAGCCCGAATTTGCTTAATTTACA-3′). Primers in-
clude the recognition sequence (in italic) for BamHI and
XhoI respectively. The PCR product was digested with these
enzymes and cloned into the corresponding sites of pXp2 vector,
upstream of the luciferase reporter gene. The resulting construct
(p2000DDD) was used to generate a series of deletion and mutant
clones.
Mutagenesis of DRE at position −42 (5′-TAACGATA-3′) on
p2000DDD was achieved by three PCR steps and subcloning of
the amplified fragment. In the first PCR, p2000DDD (template)
and primers dir(1339) and rev(820) (5′-TCAAACAATTActaTTA
TCGGTTTTGAAAATAATGA-3′) were used. In the second PCR,
the same template and primers dir(1839) (5′-TCATTATTTCAA-
AACCGATAAtagTAATTGTTTGA-3′) and rev(818) were used.
Primers rev(820) and dir(1839) are complementary and contain
the DRE at −42 (underlined) mutated (changes are in lower-case).
A third PCR was carried out using as a template an equimolar
mixture of the two obtained products and primers dir(1339) and
rev(818); it yielded a 2076 bp fragment that is identical with the
original contained in p2000DDD except for the mutated DRE at
position −42. The final PCR product was cloned into BamHI
and XhoI sites of pXp2 to generate p2000DDd. Mutagenesis
of DRE at position −48 (5′-AACCGATA-3′) was carried out as for
DRE at −42, using the mutation containing primers rev(821) (5′-
TCAAACAATTATCGTTActaGTTTTGAAAATAATGA-3′) for
the first PCR and dir(1840) (5′-TCATTATTTTCAAAACtag-
TAACGATA-3′) for the second. Primer sequences show DRE
at −48 underlined and mutation in lower-case. The product was
finally cloned to generate p2000DdD.
The double mutant DRE (−42/−48)-containing construct
was obtained in the same manner, using primers rev(822)
(5′-TCAAACAATTActaTTActaGTTTTGAAAATAATGA-3′) for
the first PCR and dir(1841) (5′-TCATTATTTTCAA AACtag-
TAAtagTAATTGTTTGA-3′) for the second. Primer sequences
show DRE at −42 in italic and that at −48 underlined and
mutations on DREs in lower-case. The product was finally cloned
in pXp2 to generate p2000Ddd.
Construction of p1300DDD, p400DDD and mutant derivatives
Construct p1300DDD was made by PCR using p2000DDD
as a template and primers dir(1299) (5′-CCAAGCTTAACTAG-
TTAACGCAATTAAGCAGC-3′; HindIII site in italic) and
rev(818). The PCR product was digested with HindIII and XhoI
and cloned into the corresponding sites of pXp2 vector.
Construct p400DDD was made in the same manner,
using as forward primer dir(1298) (5′-CCAAGCTTTGTTC-
AAAATCCTACAAGTC-3′; HindIII site in italic). Mutation of
proximal DREs (−42/−48) on p400DDD was carried out using
p2000Ddd as a template, and primers dir (1299) and rev(818)
yielding p400Ddd. To construct p400dDD (containing only the
mutated form of DRE at −361) a PCR reaction was carried
out using p2000DDD as a template and primers dir(2875) (5′-
CCAAGCTTTGTTCAAAATCCTACAAGTCTTTGTTTAGtag-
TAATGTTCCG-3′; HindIII site in italic; DRE site underlined;
mutation in DRE in lower-case) and rev(818). Finally, p400ddd
(containing mutated DRE at −361, −48 and −42) was made by
PCR using p2000Ddd as a template and primers dir(2875) and
rev(818). The product was digested with HindIII and XhoI
and cloned into the corresponding sites of pXp2 vector. All con-
structs were confirmed by sequencing.
Transient transfection assay
Transient transfection assays in Drosophila S2 cells were per-
formed as described in [17] using 5 μg of the luciferase gene
containing plasmids. To measure luciferase activity, cells were
harvested by centrifugation and washed with PBS. Cell lysis
and luciferase measurements were carried out using the
Luciferase Assay System (Promega) according to the manu-
facturer’s recommendations. Promoter activities were calculated
by normalizing luciferase activities by the β-galactosidase
activity from plasmid pAc5.1/V5-His/LacZ (Invitrogen), 1 μg of
which was co-transfected. β-Galactosidase activity was measured
using the Beta-Glo Assay System (Promega) according to the
manufacturer’s instructions.
Gel mobility-shift assay
For the mobility-shift assay, nuclear protein extract from S2 cells
(prepared as reported in [17]) was incubated with a double-
stranded 36-mer oligonucleotide (from positions −61 to −26).
The probe was 5′-end-labelled with [γ -32P]ATP and T4 poly-
nucleotide kinase and then purified using G50 NICKTM columns
(Amersham Biosciences). Binding reactions were carried out
by combining 10 μg of nuclear protein extract, 50000 c.p.m.
(corresponding to 30 fmol) of DNA probe and 1 μg of
poly(dI-dC)·poly(dI-dC) (Amersham Biosciences) in binding
buffer [20% (v/v) glycerol, 1 mM dithiothreitol, 20 mM Hepes,
pH 9.0, 5 mM MgCl2, 0.2 mM EDTA and 200 mM KCl]. After
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incubation for 30 min at 4 ◦C, the reaction products were
electrophoresed on a 6% polyacrylamide gel in 0.5 × TBE (Tris/
borate/EDTA; 1 × TBE = 45 mM Tris/borate and 1 mM EDTA).
A 200-fold molar excess of non-radioactive wild-type or DRE
mutated oligonucleotides was used as a homologous competitor.
DRE mutations in unlabelled competitors corresponded to the
same nucleotides changed in constructs for luciferase assays. In
order to produce a super-shifted band, specific anti-DREF serum
(from Laurie Kaguni, Department of Biochemistry, Michigan
State University, East Lansing, MI, U.S.A.) was added (1:200
dilution in PBS) after 15 min of binding reaction. Pre-immune
serum was used at the same dilution as a negative control.
ChIP (chromatin immunoprecipitation) assays
ChIP assays were carried out with DNA obtained from 0.45 g
of D. melanogaster overnight embryos as previously described
[23], with some minor modifications. Homogenized embryos
were sonicated five times (10 s continuous pulses at 7 amplitude
microns power) in an MSE Soniprep 150 sonifier with a micro-
tip probe at 4 ◦C, with 30 s cooling on ice between pulses, yielding
DNA fragments mostly between 200 and 700 bp. Immuno-
precipitation was made on chromatin extract without filtering
through a centricon column.
For immunoprecipitation, polyclonal anti-DREF sera from
rabbit and anti-Eyegone from guinea-pig and their respective
pre-immune sera were used. Chromatin extracts were
immunoprecipitated twice, initially with the corresponding pre-
immune serum for 6 h (IgG control to remove non-specific
interactions) and then overnight at 4 ◦C with polyclonal antiserum.
Immunoprecipitated DNA was used for PCR amplification
of proximal DRE sites using the following primers: Fw-42 (5′-
TTGTGTATGAACCAGCACAC-3′) and Rev-42 (5′-AAACAG-
CTGATATGTTGCGG-3′) as forward and reverse primers
respectively for amplifying a 225 bp fragment containing the
−42/−48 DRE site; Fw-361 (5′-ATGTGGAGTAGTGCTTGT-
GA-3′) and Rev-361 (5′-CATTCTTAGACAGAGAGTCC-3′) as
those for amplifying a 175 bp fragment including the −361 DRE
site. The PCR products (after 30 cycles of 94 ◦C/30 s; 58 ◦C/30 s;
72 ◦C/30 s) were resolved by gel electrophoresis and visualized
by ethidium bromide staining.
RNAi (RNA interference) and Western blotting assay
Templates for the production of dsRNAs (double-stranded
RNAs) were PCR-derived fragments carrying at both ends the
T7 promoter sequence. Each primer contained a 5′-end
sequence corresponding to the T7 polymerase promoter
(5′-TAATACGACTCACTATAGGGA-3′), followed by a gene-
specific sequence as indicated: DREF (accession number
NM_078805) forward-primer nt 720–736 and reverse-primer nt
1321–1306; LacZ (pUC18 vector accession number L09136)
forward-primer nt 2512–2528 and reverse-primer nt 362–348.
The PCR products were phenol-extracted, ethanol-precipitated
and used as templates for the MEGAscript® RNAi kit (Ambion)
to produce dsRNAs according to the manufacturer’s instructions.
S2 cell were maintained in Schneider’s Drosophila medium
(Gibco–Invitrogen) supplemented with 10% (v/v) foetal bovine
serum (Gibco–Invitrogen), 50 units/ml penicillin and 50 mg/ml
streptomycin, at 25 ◦C. For dsRNA treatment, cells were diluted to
a final concentration of 1.0 × 106 cells/ml in 10 ml of Schneider’s
Drosophila medium (not supplemented) in a 75-cm2 flask.
dsRNAs (15 μg per 106 cells) were added directly to the medium
and cells were incubated at 25 ◦C for 1 h. Then, 10 ml of complete
medium was added to obtain a cell density of 0.5 × 106 cells/ml
followed by an additional incubation at 25 ◦C for 72 h.
dsRNA-treated and -untreated S2 cells were then harvested,
centrifuged at 1000 g for 4 min at 4 ◦C and washed twice with
PBS. Pellets were resuspended in 1 × Laemmli buffer and
proteins were fractionated on SDS/12% (w/v) polyacrylamide
gel and electroblotted on to a PVDF membrane (Immobilon-P;
Millipore). Membranes were incubated with affinity-purified anti-
DREF antibodies (from Masamitsu Yamaguchi, Kyoto Institute
of Technology, Kyoto, Japan) and anti-actin antibodies (Sigma),
followed by an incubation with anti-rabbit IgG (Santa Cruz
Biotechnology). Protein bands were visualized using the ECL®
Plus Western Blotting Detection System (GE Healthcare).
Real-time RT–PCR (reverse transcription–PCR) assay
Total cellular RNA was extracted from dsRNA-treated and
-untreated S2 cells by using the RNeasy Midi kit (Qiagen);
500 ng of it was reverse-transcribed in a final volume of 25 μl
by using the Enhanced AMV Reverse Transcriptase kit (Sigma),
according to the manufacturer’s instructions. Real-Time PCR
was performed using the Power SYBR® Green PCR Master
Mix (Applied Biosystems) and the ABI PRISM 7000 Sequence
Detection System (Applied Biosystems). Primers were designed
using Primer Express 2.0 software (Applied Biosystems) and
the resulting sequence positions were as follows: nt 583–602
(forward), nt 683–663 (reverse) for DmTTF (accession number
AY196479); nt 2352–2371 (forward) and nt 2452–2434 (reverse)
for mtRNA pol (accession number NM_134721); nt 1407–1429
(forward) and nt 1480–1462 (reverse) for cytoplasmic 28S rRNA
(accession number M21017), which was used as an endogenous
control.
Each reaction was run in triplicate and contained 1 μl of reverse
transcription reaction (1 μl of a 1:200 dilution was used for 28S
rRNA) along with 200 nM primers in a final reaction volume
of 30 μl. Amplification conditions were: 95 ◦C for 10 min, then
40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min. To ensure that
only a single product was amplified, the melting curve analysis
was performed using the Dissociation Curves software (Applied
Biosystems). All PCR products were run on a 2.5% agarose gel
to confirm specificity. Analysis of the results was performed as
described previously [22].
In situ hybridization
In situ analysis of mtRNApol and DmTTF expression on Droso-
phila embryos was performed by incubating previously treated
embryos with antisense riboprobes, using the corresponding sense
riboprobes as negative controls.
To prepare the mtRNApol riboprobe, a fragment of its cDNA
(positions 2067–4277, according to FlyBase annotation symbol
CG4644) was previously PCR-amplified and cloned into the
EcoRV site of pGEMT-easy vector (Promega). In the same
manner, to prepare the DmTTF riboprobe, a fragment of its cDNA
(positions 113–1346 according to FlyBase annotation symbol
CG18124) was cloned into the EcoRV site of pBluescript-KS+
vector.
Preparation of embryos, riboprobes and in situ experiments
were carried out as described in [24] with minor modifications:
in point 2.3.3. ‘Hybridization, developing and visualization’,
subpoint a., PBT (phosphate buffer/0.1% Tween 20) solution was
used, and in subpoint g., developing solution containing 100 mM
NaCl was used.
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Figure 1 Multialignment of DmTTF promoters from different Drosophila species and location of DRE sequences
(A) Alignment of DmTTF proximal promoter regions from the Drosophila species of the melanogaster subgroup. Nucleotide sequences were obtained from FlyBase. The multiple alignment was
performed at NPS@ web server of the PBIL (http://npsa-pbil.ibcp.fr) using the IUB (International Union of Biochemistry) weight matrix and formatted with the ESPript 2.2 web tool (http://espript.ibcp.fr).
The arrow indicates the transcription start point according to D. melanogaster +1 site described in FlyBase. Nucleotides conserved in all sequences are shaded in black, and nucleotides conserved in
four out of five sequences are boxed. DRE sequences within the promoters are indicated by solid bars; DRE consensus sequence is also shown with the conserved and the non-conserved nucleotides
indicated in upper- and lower-case respectively. (B) Schematic representation of the location of DRE sites in DmTTF promoter-proximal regions from the different Drosophila species. DRE sequences
are represented by ellipses. Positions are relative to the D. melanogaster transcription start point.
RESULTS
DRE sequences are present in the DmTTF promoter and
are conserved in different Drosophila species
With the aim of characterizing the involvement of DREF
in controlling transcription of DmTTF and mtRNApol genes in
D. melanogaster, we searched for the DRE consensus sequence
TATCGATA in the 2 kb DNA region upstream and around
the DmTTF and mtRNApol transcription initiation sites that,
according to FlyBase (http://www.flybase.org/), are located 112
and 168 nt upstream of the translation start codon respectively. In
the case of the mtRNApol promoter, no DREF-binding motifs
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Figure 2 Functional analysis of the DmTTF promoter region
A schematic representation of the DmTTF promoter region containing the putative DRE sites is shown (top panel). The hatched box represents the 5′-UTR. Transcription and translation initiation sites
are indicated by thin arrows. DRE sequences are represented as grey ellipses and numbers indicate their positions with respect to the transcription initiation site. Constructs used for the analysis of
promoter activity are shown (bottom panel); the position of the ends of the fragments cloned upstream of the luciferase (luc) reporter gene (dark grey arrow) is indicated; a black ellipse indicates that
the DRE sequence is mutated. The relative promoter activities measured in the luciferase assay are represented by the corresponding black horizontal bars. Luciferase activity of the 2 kb promoter
region was defined as 100 %. Luciferase activity was normalized to β-galactosidase activity for each transfection. Results are means +− S.D. (n 6). Statistical analysis was carried out using one-way
ANOVA and the Bonferroni post-test (***P < 0.001 and **P < 0.01).
were identified. On the contrary, the analysis of the DmTTF
promoter allowed the identification of ten putative DREs scattered
between positions −42 and −1899, according to the transcription
start point, which retain at least 6 out of the 8 nt of the DRE
consensus sequence (see Figure 2). Three of these elements are
located within the proximal 400 bp region, specifically at −42,
−48 and −361, and match 7, 6 and 6 nt out of the 8 forming DRE
consensus respectively (see Figure 1A). The element in position
−42 overlaps by 2 nt with that in position −48. Comparison of
the promoter proximal sequence in five Drosophila species (D.
simulans, D. sechellia, D. melanogaster, D. yakuba and D. erecta)
showed 100% conservation in the sequence of all the three DREs
(Figure 1A) as well as in the relative positions of the two most
proximal, with the position of the third DRE sequence being very
similar (Figure 1B).
Role of DRE sites in DmTTF promoter activity
Transient transfection experiments in S2 cells were carried out
in order to analyse the role of DRE sequences in DmTTF
promoter function. For this purpose, different deleted and/or point
mutated versions of DmTTF upstream sequences were linked
to a luciferase reporter gene in the pXp2 vector. As shown in
Figure 2, the luciferase activity promoted by a fragment of 2076 bp
(p2000DDD), spanning positions −1964 to +112 according to
the transcription start point, was fixed at 100%.
Deletion mutant analysis showed that the removal of up to
1577 bp from the distal end of the promoter sequence did
not significantly alter transcription efficiency, since p1300DDD
and p400DDD mutants show approximately the same luciferase
activity as p2000DDD. The 400 bp promoter proximal region,
which retains almost 90% of the total promoter activity, contains
the three conserved DRE sequences located at positions −42,
−48 and −361.
Different combinations of these proximal DRE sites containing
changes in the tri-nucleotide core of the consensus (positions 4–6)
were generated in p2000DDD and p400DDD and used in transient
transfection assays. Comparison of luciferase activity obtained
with the wild-type and mutated versions of p2000 (Figure 2)
indicates that mutation of DRE at either the −42 (p2000DDd)
or the −48 (p2000DdD) site causes a significant reduction in the
promoter activity (approx. 30%); the reduction reaches approx.
50% when both sites are mutated (p2000Ddd). The relevance
of the proximal double −42/−48 DRE sequences is confirmed
by the double mutation in p400Ddd, which causes an even
higher reduction, approx. 60%, of the reporter gene expression
than that in p2000Ddd. Finally, mutation of the distal −361
DRE sequence (p400dDD) causes 40% reduction in promoter
efficiency, showing that this third DRE site also participates in
DmTTF transcription in S2 cells.
In conclusion, this analysis indicates that (i) DREs are involved
in DmTTF transcription, (ii) there are three functional DREs in
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Figure 3 Binding of DREF to the DRE sites in the DmTTF promoter region
DREF binding was evaluated by gel-shift analysis using a nuclear extract (10 μg of protein) from S2 cells and a radiolabelled 36-mer double-stranded oligonucleotide (positions −61 to −26,
relative to the DmTTF transcription initiation site) containing the −42 and −48 DRE sites. Homologous cold competitors (where cold indicates unlabelled), added to the assay in a 200-fold molar
excess, were different versions of the same 36-mer oligonucleotide used as a probe. With respect to the wild-type (DD), the versions mutated in the −48 site (dD), in the −42 site (Dd) or in both
sites (dd) contain the same three nucleotide changes used for the luciferase assay constructs. The black arrows indicate the protein–DNA complexes, the white arrow indicates the super-shifted band
produced by adding anti-DREF serum to the binding reaction.
the DmTTF promoter and (iii) mutations on proximal DRE sites
abolish 50–60% of the promoter activity.
Binding of DREF to DmTTF promoter
To demonstrate that DRE sequences in the DmTTF promoter are
recognized by DREF, gel mobility-shift and ChIP assays were
carried out.
Gel mobility-shift experiments were performed using S2
cell nuclear extracts and a 32P-labelled 36-mer double-stranded
oligonucleotide containing the −42 and −48 DRE sites. The
electrophoretic analysis (Figure 3) shows the formation of two
protein–DNA complexes (lane 2) that were completely abolished
by an excess of homologous unlabelled competitor (lane 3).
Moreover, we used as unlabelled competitor oligonucleotides
containing a mutated version of each or both DRE sites. As
shown in Figure 3, the oligonucleotide containing mutation at
the −42 site still keeps a high competition capacity (lane 5),
whereas the oligonucleotide mutated at the −48 site shows a
reduced capacity to compete (lane 4). As expected, the double
mutant oligonucleotide is almost completely unable to compete
(lane 6). These results suggest that the protein contacting the DNA
probe is DREF; moreover, they indicate that the −48 element has
a higher affinity for the protein than that at −42. To produce clear
evidence of the involvement of DREF in binding to the DmTTF
promoter, we performed the binding reaction in the presence of
anti-DREF serum: as shown in Figure 3 (lanes 7–9), we observed a
clear super-shift of the retarded bands; super-shift was observed
neither in the presence of an excess of homologous unlabelled
competitor nor in the sample containing the pre-immune serum.
The results obtained clearly demonstrate that the two DNA–
protein complexes contain DREF.
To analyse the in vivo binding of DREF to the DmTTF promoter,
we performed ChIP experiments on D. melanogaster whole
embryos. Chromatin was immunoprecipitated with anti-DREF
antibodies and the bound DNA was identified by PCR amplifica-
tion with primers specific for either the −42/−48 or −361 DREs
(Figure 4). As a negative control, PCR amplifications were also
made on chromatin immunoprecipitated with anti-Eyegone serum
[25]. As shown in Figure 4, PCR amplified a clear, single and in-
tense band for −42/−48 and −361 DREs when the template was
the chromatin immunoprecipitated by anti-DREF, but no ampli-
fication, or a very faint band for −42/−48 region, was observed
when the template was the chromatin immunoprecipitated by pre-
immune and anti-Eyegone serum. These results demonstrated that
DREF binds in vivo to proximal DREs on the DmTTF promoter
region. ChIP experiments on SL2 cells also produced similar res-
ults to those of ChIP experiments on embryos (results not shown).
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Figure 4 DREF binds to proximal DRE sites in the DmTTF promoter in vivo
Overnight D. melanogaster embryos were fixed to cross-link proteins to DNA. Embryos were homogenized, cells were lysed and their DNA fragmented by sonication. Cell lysates were immunoprecipitated
with control IgG (pre-immune serum) or polyclonal antiserum raised against DREF or Eyegone. Immunoprecipitated DNAs were amplified by PCR with specific primers for −42/−48 DRE sites
(A) and for −361 DRE site (B). DNA templates, immunoprecipitated in different conditions, are indicated above each lane. Input lanes show the PCR product derived from chromatin prior to
immunoprecipitation. M corresponds to 1 kb DNA ladder (Invitrogen) and the sizes of the fragments are indicated on the left-hand side (in bp). The experiment was repeated twice, yielding similar
results.
Effect of DREF knock-down on DmTTF and mtRNApol expression in
S2 cultured cells
We finally investigated the effect of DREF knock-down on
DmTTF endogenous gene transcription in Drosophila cultured
cells. Moreover, since DREF is known to be involved in a complex
network of regulatory pathways [11], and it could not be excluded
that mtRNApol expression could also be indirectly regulated by
the DRE/DREF system, we also tested the effect of DREF deple-
tion on mtRNApol mRNA. To this purpose, we used the RNAi
procedure to obtain DREF depletion in S2 cells. After treating
cells for 72 h with a dsRNA encompassing 601 nt of DREF
coding sequence, the level of DREF polypeptide was monitored by
Western blotting assay. As reported in Figure 5(A), a decrease of
more than 90% in DREF level was obtained; the effect of DREF
RNAi was specific as no effect was observed in cells treated with
dsRNA containing the sequence of the LacZ gene (mock control).
Then, we measured the steady-state level of DmTTF and
mtRNApol mRNAs using real-time RT–PCR. As shown in
Figure 5(B), results obtained from five independent RNAi
experiments indicate that in DREF-depleted S2 cells the level
of DmTTF mRNA is approx. 55% of that in non-depleted cells.
On the other hand, no effect of DREF depletion was observed on
the mtRNApol mRNA level. The decrease in DmTTF mRNA is
consistent with the results obtained from the transient transfection
assay, and confirms that DREF is a transcription factor controlling
DmTTF gene expression.
Spatial and temporal expression of DmTTF and mtRNApol genes
during D. melanogaster development
To study the spatial and temporal expression of DmTTF and
mtRNApol during embryogenesis, we used whole-mount in situ
RNA hybridization. Figure 6(A) shows that DmTTF mRNA has a
significant maternal deposit; until stage 12, the signal appears to be
quite uniform except for ectoderm and polar cells, where there is
no expression (only stage 6 is shown; the polar cells results are not
shown). At stage 12, DmTTF mRNA level is increased in midgut
(digestive tube) over a general background. From stage 13, the gut
and Malpighi tubes show a higher content of DmTTF transcript
than the rest of the embryo. Figure 6(B) shows that mtRNApol
mRNA also has a significant maternal deposit that disappears
before stage 4. Zigotic transcription starts approximately at stage
11, when the hybridization signal appears exclusively in gut
primordia. Approximately from stage 12, a strong signal is present
in the gut, pharyngeal muscles and mesoderm and seems to be
absent or undetectable in the rest of the embryo. Finally, from
stage 13, the mtRNApol transcript is relatively highly expressed
in the gut, pharyngeal muscles, Malpighi tubes and somatic
mesoderm.
DISCUSSION
DREF is a Drosophila key transcription factor that regulates the
expression of a set of genes involved in nuclear DNA replication
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Figure 5 Effect of DREF knock-down on DmTTF and mtRNApol mRNA levels
(A) DREF protein was knocked down in S2 cells by means of RNAi. Cells, either untreated (control) or treated with LacZ (mock) or DREF dsRNA, were harvested and proteins were subjected to
SDS/PAGE and Western-blot analysis with polyclonal antibodies against DREF and β-actin. (B) Total RNA was extracted from treated and untreated cells and relative quantification of mRNAs was
carried out by real-time RT–PCR. Bars indicate the relative content of transcripts, normalized to 28S rRNA (endogenous control), in treated with respect to control cells fixed at the value 1. The relative
quantification was performed according to the Pfaffl equation [26]. Values are expressed as a ratio and results are means +− S.D. (n = 5). Statistical analysis was performed using paired two-tailed
Student’s t test (*P < 0.05).
and cell cycle control [8–11]. Moreover, transcription regulation
by DREF was demonstrated for the expression of protein
factors directly involved in mtDNA replication and maintenance
[16–18].
With the aim of providing a contribution to the study of
mitochondrial biogenesis in D. melanogaster, we focused our
attention on the putative regulation by DREF of two nuclear
genes coding for mitochondrial proteins belonging to the
mtDNA transcription apparatus: mtRNApol and the transcription
termination factor DmTTF.
We first analysed in silico the 5′-flanking region of the DmTTF
and mtRNApol genes by searching for DREs. This allowed the
identification of ten DRE sequences in the promoter region of
the DmTTF gene, the three most proximal of which are 100%
conserved in the Drosophila species belonging to the melano-
gaster subgroup. No significant DREs were found in the mtRNA-
pol promoter. Afterwards, by both in vivo and in vitro experiments
we clearly demonstrate that DREs are required for DmTTF pro-
moter activity and that DREF positively regulates the expression
of the transcription termination factor. Our study thus provides
the first experimental evidence of a control exerted by DREF on
a factor involved in mtDNA transcription. On the other hand, our
results rule out the possibility that DREF controls, although indir-
ectly, the mtRNApol gene at least in S2 cells. It has been determ-
ined recently that DREF also stimulates the expression of another
transcription factor, namely TFB2M, which is involved in tran-
scription initiation (M. ´A. Ferna´ndez-Moreno, unpublished work).
Therefore our findings on the mtDNA transcription machinery
parallel what was observed for the mtDNA replication apparatus,
that is, the accessory factors are controlled by DREF, whereas the
catalytic polypeptides, mtRNApol and pol γ -α [17], are not.
The transcription termination factor DmTTF belongs to the
mTERF protein family that includes three more members from D.
melanogaster [20,27]; as reported in FlyBase, they are indicated
as CG7175, CG15390 and CG5047, with the last polypeptide
being named D-MTERF3 and was shown to be involved in
mitochondrial protein synthesis [27]. We found that multiple DRE
sequences are also present in the 5′-flanking sequences of the
genes for all these three proteins (F. Bruni, unpublished work),
thus suggesting the existence of a control by DREF on all the genes
belonging to the mTERF family and pointing towards a more
general role of DREF in the control of mitochondrial biogenesis
in Drosophila. This hypothesis is further supported by the recent
finding that the DRE/DREF system is also a crucial regulator of
ANT (adenine nucleotide translocase) gene expression [28].
It has been reported that hDREF (human DREF), the human
orthologue of the Drosophila factor, regulates cell proliferation
and expression of ribosomal protein genes [29,30]. Interestingly,
we found that the gene for the human mitochondrial transcription
termination factor mTERF contains a putative recognition site
for hDREF in the 5′-UTR (5′-untranslated region). A similar
observation has been reported also for the human ANT gene
[28]. These findings suggest that hDREF might have a role in
controlling the expression of these genes and that some regulatory
patterns of mitochondrial biogenesis could be shared by humans
and Drosophila.
In situ RNA hybridization studies on Drosophila embryos
reported here show that DmTTF mRNA is transcribed almost
ubiquitously and constitutively; mtRNApol expression seems to
be more efficient and restricted to specific embryonic territories.
However, in the late stages of embryogenesis, DmTTF trans-
cription becomes, over a general background, more efficient in
c© The Authors Journal compilation c© 2009 Biochemical Society
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Figure 6 DmTTF and mtRNApol expression during Drosophila embryogenesis
The temporal and spatial distribution of Drosophila DmTTF (A) and mtRNApol (B) was examined by whole-mount in situ hybridization with digoxigenin-labelled antisense RNA as described in the
Materials and methods section. The staining pattern of embryos is shown at the indicated stages. All stages are shown in lateral view with the dorsal at the top, except for the 14th and 15th stages
that are shown in dorsal view. Both mRNAs display a significant maternal deposit. DmTTF mRNA is present in all stages and almost ubiquitously; after the 12th stage, it is transcribed more efficiently
in the gut, and after the 13th stage, it is transcribed in the gut and Malpighi tubes (the latter are out of focus in the dorsal view). mtRNApol mRNA maternal deposit disappears before the 4th stage
until the 11th approximately when it is efficiently transcribed in the gut. In late stages of the process, mtRNApol is efficiently and specifically transcribed in the gut, mesoderm, Malpighi tubes and
pharyngeal muscles (the latter are out of focus in the dorsal view). amg, anterior midgut; ec, ectoderm; mg, midgut; ms, mesoderm; mt, Malpighi tubes; pm, pharyngeal muscles; pmg, posterior
midgut.
Malpighi tubes and the gut (digestive tube), regions in which
mtRNApol is also transcribed. Thus it is interesting that the
mRNAs for DmTTF and mtRNApol, two proteins involved in
the same process, share some expression regions but do not
show identical temporal and spatial expression patterns during
embryogenesis; this confirms that transcription of the two genes
is differentially regulated. Moreover, the data obtained imply
that higher levels of DmTTF might be required in territories
such as Malpighi tubes and the gut. A similar situation can
be inferred from the data for DmTTF and mtRNApol gene
transcription in Drosophila larvae and adult tissues reported in the
FlyAtlas database (http://www.flyatlas.org/) [31]. In particular,
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the enrichment of mtRNApol in some adult tissues with respect
to the whole fly is slightly different from that of DmTTF (1.1
versus 0.8 in brain, 0.8 versus 1.2 in crop and 0.6 versus 1.0 in
tubule). This imbalance is higher in larval tissues such as larval
tubule (0.2 versus 1.0) or larval fat body (0.2 versus 1.1).
Our findings and those from FlyAtlas suggest the possibility
that DmTTF could play multiple roles in the mtDNA transcription
process, for which different levels of the protein with respect to
mtRNApol are required. This possibility is also supported by
DmTTF RNAi data [22], which indicate a possible function of
the termination factor also in transcription initiation. Therefore
we suggest that variation in the relative amount of DmTTF
might control, for example, the balance of different groups
of mitochondrial transcripts during embryo development and,
possibly, in larvae. Further experimental work is necessary to
gather evidence in support of this proposal.
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